ClinicalTrials.gov
ClinicalTrials.gov Menu

Capecitabine, Oxaliplatin, and Gefitinib in Treating Patients With Metastatic Colorectal Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00087334
Recruitment Status : Terminated (Withdrawn due to poor/low accrual)
First Posted : July 12, 2004
Last Update Posted : February 1, 2013
Sponsor:
Information provided by (Responsible Party):
Roswell Park Cancer Institute

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : November 2005
  Study Completion Date : No date given